Mycophenolate mofetil Recruiting Phase 2 Trials for Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities / Secondary Myelodysplastic Syndromes / Aplastic Anaemia (AA) / Refractory Anemia / Adult Acute Myeloid Leukemia With T(8;21)(q22;q22) / Recurrent Adult Acute Myeloid Leukemia / Childhood Acute Lymphoblastic Leukemia in Remission / Refractory Multiple Myeloma / Essential Thrombocythemia (ET) / Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue / Adult Acute Myeloid Leukemia in Remission / Recurrent Grade 2 Follicular Lymphoma / Recurrent Grade 1 Follicular Lymphoma / T-Cell Large Granular Lymphocyte Leukemia / Splenic Marginal Zone Lymphoma / Adult Acute Myeloid Leukemia With T(16;16)(p13;q22) / Childhood Acute Myeloid Leukemia in Remission / Adult Acute Myeloid Leukemia With Del(5q) / Waldenström's Macroglobulinemia (WM) / Recurrent Marginal Zone Lymphoma / Recurrent Adult Acute Lymphoblastic Leukemia / Chronic Neutrophilic Leukemia / Adult Acute Myeloid Leukemia With T(15;17)(q22;q12) / Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) / Refractory Hairy Cell Leukemia / Recurrent Small Lymphocytic Lymphoma / Recurrent Childhood Acute Lymphoblastic Leukemia / Previously Treated Myelodysplastic Syndromes / Primary Myelofibrosis / Juvenile Myelomonocytic Leukemia / Polycythemia Vera (PV) / Recurrent Adult Grade III Lymphomatoid Granulomatosis / Recurrent Childhood Acute Myeloid Leukemia / Recurrent/Refractory Childhood Hodgkin Lymphoma / Adult Acute Lymphoblastic Leukemia in Remission / Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma / Refractory Anemia With Ringed Sideroblasts / Chronic Myelomonocytic Leukemia / Recurrent Mycosis Fungoides/Sezary Syndrome / Adult Nasal Type Extranodal NK/T-Cell Lymphoma / Recurrent Adult Hodgkin's Lymphoma / Urticaria Pigmentosa / Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable / Nodal marginal zone B-cell lymphomas / Chronic Eosinophilic Leukemia (CEL) / Recurrent Adult Diffuse Small Cleaved Cell Lymphoma / Childhood Myelodysplastic Syndromes Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01384513A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies